10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q1 2015

Filing Information

Form Type	10-Q
Accession Number	`0001213900-14-007845`
Period End Date	20140930
Filing Date	20141107
Fiscal Year	2015
Fiscal Period	Q1
XBRL Instance	relm-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 54 Income Statement 24 Cash Flow Statement 63

Balance Sheet 54 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$27.39M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$178.16K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$427.62K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$25.74M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.82M	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$16.92K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$9.84K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Other assets	`OtherAssets`	$12.10K	USD	Point-in-time
Other assets	`OtherAssets`	$12.10K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.85M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.29M	shares	Point-in-time
Total assets	`Assets`	$27.85M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.85M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.29M	shares	Point-in-time
Total assets	`Assets`	$25.76M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$624.73K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$746.10K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$382.02K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$879.50K	USD	Point-in-time
Notes payable	`ConvertibleNotesPayableCurrent`	$148.32K	USD	Point-in-time
Notes payable	`ConvertibleNotesPayableCurrent`	$58.36K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$46.82M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$25.59M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.77M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$48.47M	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$100.00K	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$100.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$48.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.87M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 500,000,000 shares authorized, 43,853,804 and 40,294,217 shares issued and outstanding, respectively	`CommonStockValue`	$40.29K	USD	Point-in-time
Common stock, $0.001 par value, 500,000,000 shares authorized, 43,853,804 and 40,294,217 shares issued and outstanding, respectively	`CommonStockValue`	$43.85K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$64.39M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$54.17M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$55.32M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$85.16M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-20.72M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$25.76M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$27.85M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Revenue	`LicenseAndServicesRevenue`	-	USD	1 Quarter
Revenue	`LicenseAndServicesRevenue`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$-274.37K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$-718.97K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$-207.46K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$-3.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$-481.84K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$-3.72M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-481.84K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.72M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-1.02M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-26.11M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.12K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$3.27K	USD	1 Quarter
Interest expense	`InterestExpense`	$67.01K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-1.08M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-26.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-29.84M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.57M	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.73	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.64	USD	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	40.73M	shares	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.45M	shares	1 Quarter

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-29.84M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.57M	USD	1 Quarter
Depreciation expense	`Depreciation`	$3.59K	USD	1 Quarter
Depreciation expense	`Depreciation`	-	USD	1 Quarter
Common stock issued for services	`CommonStockIssuedForServices`	$-16.92K	USD	1 Quarter
Common stock issued for services	`CommonStockIssuedForServices`	$-875.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$157.99K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$9.48K	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$1.02M	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$26.11M	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$20.46K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$4.80K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-10.56K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$11.06K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-121.36K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.05K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$76.88K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$497.47K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-408.70K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.32M	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$762.00	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$10.67K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.67K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-762.00	USD	1 Quarter
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	$4.31M	USD	1 Quarter
Net proceeds from the exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Principal payments of note payable	`RepaymentsOfNotesPayable`	$148.44K	USD	1 Quarter
Principal payments of note payable	`RepaymentsOfNotesPayable`	-	USD	1 Quarter
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	1 Quarter
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.30M	USD	1 Quarter
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	$501.60K	USD	1 Quarter
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.16M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.80M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$1.83M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashPeriodIncreaseDecrease`	$2.39M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$27.39M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$27.39M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.95M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.56M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaidNet`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	$3.27K	USD	1 Quarter
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	$293.62K	USD	1 Quarter
Financing of insurance premiums by issuance of note payable	`FinancingOfNotePayable`	-	USD	1 Quarter
Cancellation of note payable for insurance premiums	`CancellationOfNotePayable`	$55.22K	USD	1 Quarter
Cancellation of note payable for insurance premiums	`CancellationOfNotePayable`	-	USD	1 Quarter
Reclassification of warrant liabilities to additional paid-in-capital for warrant exercises	`FairValueAdjustmentOfWarrants`	$4.88M	USD	1 Quarter
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	-	USD	1 Quarter
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	$1.16M	USD	1 Quarter
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	$83.36K	USD	1 Quarter
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	-	USD	1 Quarter
Fair value of warrants issued in connection with deferred financing costs	`FairValueOfWarrantsIssuedInConnectionWithDeferredFinancingCosts`	$41.68K	USD	1 Quarter
Fair value of warrants issued in connection with deferred financing costs	`FairValueOfWarrantsIssuedInConnectionWithDeferredFinancingCosts`	-	USD	1 Quarter
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	$163.62K	USD	1 Quarter
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.